Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal

Open access

Published version of a preprint

Abstract

International cancer registries make real-world genomic and clinical data available, but their joint analysis remains a challenge. AACR Project GENIE, an international cancer registry collecting data from 19 cancer centers, makes data from >130,000 patients publicly available through the cBioPortal for Cancer Genomics (https://genie.cbioportal.org). For 25,000 patients, additional real-world longitudinal clinical data, including treatment and outcome data, are being collected by the AACR Project GENIE Biopharma Collaborative using the PRISSMM data curation model. Several thousand of these cases are now also available in cBioPortal. We have significantly enhanced the functionalities of cBioPortal to support the visualization and analysis of this rich clinico-genomic linked dataset, as well as datasets generated by other centers and consortia. Examples of these enhancements include (i) visualization of the longitudinal clinical and genomic data at the patient level, including timelines for diagnoses, treatments, and outcomes; (ii) the ability to select samples based on treatment status, facilitating a comparison of molecular and clinical attributes between samples before and after a specific treatment; and (iii) survival analysis estimates based on individual treatment regimens received. Together, these features provide cBioPortal users with a toolkit to interactively investigate complex clinico-genomic data to generate hypotheses and make discoveries about the impact of specific genomic variants on prognosis and therapeutic sensitivities in cancer. Significance: Enhanced cBioPortal features allow clinicians and researchers to effectively investigate longitudinal clinico-genomic data from patients with cancer, which will improve exploration of data from the AACR Project GENIE Biopharma Collaborative and similar datasets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-23-0816

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Integration of the longitudinal clinico-genomic data from AACR GENIE BPC in cBioPortal. Multidimensional GENIE BPC datasets have been harmonized across the four participating centers. AACR Project GENIE includes molecular and basic clinical data from 19 institutions. GENIE BPC enriches this data for four institutions with additional clinical longitudinal elements. The data are publicly available in cBioPortal (https://genie.cbioportal.org). The complete clinical and genomic data can be downloaded from Synapse (https://www.synapse.org/genie).
Figure 1. Integration of the longitudinal clinico-genomic data from AACR GENIE BPC in cBioPortal. Multidimensional GENIE BPC datasets have been harmonized across the four participating centers. AACR Project GENIE includes molecular and basic clinical data from 19 institutions. GENIE BPC enriches this data for four institutions with additional clinical longitudinal elements. The data are publicly available in cBioPortal (https://genie.cbioportal.org). The complete clinical and genomic data can be downloaded from Synapse (https://www.synapse.org/genie).CC BY-NC-ND · PubMed Central
Figure 2. Visualization of longitudinal clinical and genomic profile of a patient in GENIE BPC. A, The timeline shows biopsies and resections, diagnoses, lines of treatments, as well as assessments from imaging and medical oncology. B, The genomic event tables show detailed information about mutations, structural variants, and copy-number alterations in each of the samples. The mutations table for instance shows the effect on the protein and the variant allele frequency. The samples column in each of the tables indicates in which sample(s) the event was found; a dash indicates that the sample was not profiled for that gene. All genomic events have an annotation column with information from other resources about that event, including, for example, OncoKB, which is indicated by a blue target icon. Hovering over those icons gives additional information in a tooltip. C, The tooltip is shown for the OncoKB annotation of ALK G1202R. It mentions that the ALK G1202R mutation identified in sample 4 is a known resistance mutation to crizotinib.
Figure 2. Visualization of longitudinal clinical and genomic profile of a patient in GENIE BPC. A, The timeline shows biopsies and resections, diagnoses, lines of treatments, as well as assessments from imaging and medical oncology. B, The genomic event tables show detailed information about mutations, structural variants, and copy-number alterations in each of the samples. The mutations table for instance shows the effect on the protein and the variant allele frequency. The samples column in each of the tables indicates in which sample(s) the event was found; a dash indicates that the sample was not profiled for that gene. All genomic events have an annotation column with information from other resources about that event, including, for example, OncoKB, which is indicated by a blue target icon. Hovering over those icons gives additional information in a tooltip. C, The tooltip is shown for the OncoKB annotation of ALK G1202R. It mentions that the ALK G1202R mutation identified in sample 4 is a known resistance mutation to crizotinib.CC BY-NC-ND · PubMed Central
Figure 3. Visualization and analysis of GENIE BPC dataset in cBioPortal. A, Study view. Overview of clinical and genomic data of the GENIE BPC NSCLC cohort; samples can be selected by their treatment status and then compared. B, Comparison view. Example comparison of samples collected before and/or after a patient was treated with crizotinib to identify genomic alterations potentially responsible for acquired resistance to treatment. C, Results view. OncoPrint with resistance alterations in post-crizotinib samples and a lollipop highlighting resistance mutations in the kinase domain of ALK. D, Survival analysis, showing a comparison of survival between TP53 mutant versus wild-type patients with NSCLC.
Figure 3. Visualization and analysis of GENIE BPC dataset in cBioPortal. A, Study view. Overview of clinical and genomic data of the GENIE BPC NSCLC cohort; samples can be selected by their treatment status and then compared. B, Comparison view. Example comparison of samples collected before and/or after a patient was treated with crizotinib to identify genomic alterations potentially responsible for acquired resistance to treatment. C, Results view. OncoPrint with resistance alterations in post-crizotinib samples and a lollipop highlighting resistance mutations in the kinase domain of ALK. D, Survival analysis, showing a comparison of survival between TP53 mutant versus wild-type patients with NSCLC.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 2

  1. Schrag, 2018, GENIE: real-world application
  2. Jack, 2000, International classification of diseases for oncology: ICD-O

Cited by

See all 891

Metadata

Authors
de Bruijn, I., Kundra, R., Mastrogiacomo, B., Tran, T. N., Sikina, L., Mazor, T., Li, X., Ochoa, A., Zhao, G., Lai, B., Abeshouse, A., Baiceanu, D., Ciftci, E., Dogrusoz, U., Dufilie, A., Erkoc, Z., Garcia Lara, E., Fu, Z., Gross, B., Haynes, C., Heath, A., Higgins, D., Jagannathan, P., Kalletla, K., Kumari, P., Lindsay, J., Lisman, A., Leenknegt, B., Lukasse, P., Madela, D., Madupuri, R., van Nierop, P., Plantalech, O., Quach, J., Resnick, A. C., Rodenburg, S. Y. A., Satravada, B. A., Schaeffer, F., Sheridan, R., Singh, J., Sirohi, R., Sumer, S. O., van Hagen, S., Wang, A., Wilson, M., Zhang, H., Zhu, K., Rusk, N., Brown, S., Lavery, J. A., Panageas, K. S., Rudolph, J. E., LeNoue-Newton, M. L., Warner, J. L., Guo, X., Hunter-Zinck, H., Yu, T. V., Pilai, S., Nichols, C., Gardos, S. M., Philip, J., AACR Project GENIE BPC Core Team, A. P. G. C., Kehl, K. L., Riely, G. J., Schrag, D., Lee, J., Fiandalo, M. V., Sweeney, S. M., Pugh, T. J., Sander, C., Cerami, E., Gao, J., & Schultz, N.
Affiliations
  • 1Memorial Sloan Kettering Cancer Center, New York, New York.
  • Memorial Sloan Kettering Cancer Center (US)
  • Dana-Farber Cancer Institute (US)
  • The Hyve (Netherlands) (NL)
  • 5Bilkent University, Ankara, Turkey.
  • 3Dana-Farber Cancer Institute, Boston, Massachusetts.
  • 4The Hyve, Utrecht, the Netherlands.
  • Children's Hospital of Philadelphia (US)
  • University Health Network (CA)
  • Vanderbilt University Medical Center (US)
  • Brown University (US)
  • Sage Bionetworks (US)
  • American Association For Cancer Research (US)
  • Harvard University (US)
Venue
Cancer Research
Published
2023-09-05
Volume
83
Issue
23
Pages
3861-3867
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W4386438154
Cited by
886
References
17
Citations by year
2026: 236 · 2025: 414 · 2024: 214 · 2023: 22
FWCI
112.48
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Bilkent University Institutional Repository (Bilkent University) (submittedVersion)
Funders
  • American Association for Cancer Research
  • National Cancer Institute (CA274633, CA264028, CA233243, CA008748, CA143840)
  • Prostate Cancer Foundation
  • Stand Up To Cancer
  • Ben and Catherine Ivy Foundation
  • National Center for Research Resources (RR 031228-02)
  • Adenoid Cystic Carcinoma Research Foundation
  • Breast Cancer Research Foundation
  • Cholangiocarcinoma Foundation
  • Robertson Foundation
  • Parker Institute for Cancer Immunotherapy
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
Keywords
cBioPortal, AACR Project GENIE, longitudinal clinical data, cancer genomics, cancer registry, survival analysis, treatment regimens, treatment sensitivity, data visualization, data curation
MeSH terms
Humans, Neoplasms, Genomics, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. https://app.cochat.ai/papers/10.1158/0008-5472.can-23-0816
The paper
de Bruijn, I., Kundra, R., Mastrogiacomo, B., Tran, T. N., Sikina, L., Mazor, T., Li, X., Ochoa, A., Zhao, G., Lai, B., Abeshouse, A., Baiceanu, D., Ciftci, E., Dogrusoz, U., Dufilie, A., Erkoc, Z., Garcia Lara, E., Fu, Z., Gross, B., . . . Schultz, N. (2023). Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Research. https://doi.org/10.1158/0008-5472.can-23-0816

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.